Back to Search
Start Over
Desferrioxamine related maculopathy: A case report
- Source :
- American Journal of Hematology. 76:386-388
- Publication Year :
- 2004
- Publisher :
- Wiley, 2004.
-
Abstract
- Desferrioxamine is used for the treatment of chronic iron overload, acute iron poisoning, and certain anaemias. Ocular toxicity secondary to prolonged treatment with desferrioxamine may result in night blindness, visual field constriction, cataract, pigmentary retinopathy and optic neuropathy. To avoid such complications an ophthalmic screening has been suggested for patients taking desferrioxamine. We report an 81-year-old patient who developed irreversible ocular toxicity despite undergoing ophthalmic screening.
- Subjects :
- medicine.medical_specialty
Iron Overload
Blood transfusion
Visual acuity
genetic structures
Iron
medicine.medical_treatment
Eye disease
Vision Disorders
Visual Acuity
Deferoxamine
Iron Chelating Agents
Iron poisoning
Diagnosis, Differential
Optic neuropathy
Macular Degeneration
Retinal Diseases
Ophthalmology
medicine
Humans
Macula Lutea
Pigment Epithelium of Eye
Aged
Aged, 80 and over
business.industry
Transfusion Reaction
Hematology
Macular degeneration
medicine.disease
Leukemia, Lymphocytic, Chronic, B-Cell
eye diseases
Surgery
Maculopathy
Female
sense organs
Atrophy
medicine.symptom
business
Glaucoma, Open-Angle
medicine.drug
Subjects
Details
- ISSN :
- 10968652 and 03618609
- Volume :
- 76
- Database :
- OpenAIRE
- Journal :
- American Journal of Hematology
- Accession number :
- edsair.doi.dedup.....d7acf226ac52bdefe1cb712cb00234ca